First Time Loading...

Arvinas Inc
NASDAQ:ARVN

Watchlist Manager
Arvinas Inc Logo
Arvinas Inc
NASDAQ:ARVN
Watchlist
Price: 32.82 USD 1.2% Market Closed
Updated: May 4, 2024

Arvinas Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arvinas Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Arvinas Inc
NASDAQ:ARVN
Revenue
$78.5m
CAGR 3-Years
53%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$85.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$61.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$35.9B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is Arvinas Inc's Revenue?
Revenue
78.5m USD

Based on the financial report for Dec 31, 2023, Arvinas Inc's Revenue amounts to 78.5m USD.

What is Arvinas Inc's Revenue growth rate?
Revenue CAGR 5Y
41%

Over the last year, the Revenue growth was -40%. The average annual Revenue growth rates for Arvinas Inc have been 53% over the past three years , 41% over the past five years .